TrialRMD open2025

Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy.

Kevin L Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.